General Research
Model: human
Effects of concomitant use of hydrogen water and photobiomodulation on Parkinson disease: A pilot study
Simplified Version Available
Hydrogen Water and Light Therapy: A Promising Duo for Parkinson's Disease
A recent study from Taiwan explores the effects of combining hydrogen water and photobiomodulation on Parkinson's disease, showing promising results in reducing symptoms. Hydrogen water has antioxidant properties, while photobiomodulation is a type of light therapy that stimulates cellular processes. The combination may help reduce oxidative stress, alleviating symptoms of Parkinson's disease.
Read Simplified ArticleAbstract
Publish Year 2021 Country Taiwan Rank Positive Journal Medicine Primary Topic Brain Secondary TopicParkinson's Disease Model Human Tertiary TopicOxidative Stress Vehicle Water, Commercial (I-Mizu Platinum) pH Alkaline Application Ingestion Comparison Complement Photobiomodulation (PBM)
Background
Methods: We included 18 patients with PD (age 30-80 years) who were at Hoehn and Yahr stages II-III. All the participants received daily PBM + H2 therapy for 2 weeks. The adverse event and the Unified Parkinson Disease Rating Scale (UPDRS) scores were recorded.
Methods
Results: We noted that the UPDRS scores began significantly decreasing from the first week, and this improvement persisted until the end of therapy. Moreover, no adverse event was recorded. After 1 week of therapy cessation, UPDRS scores slightly increased but the improvement remained significant compared with the baseline.
Results
Conclusion: This novel, proof-of-concept study demonstrated that PBM+H2 therapy is safe and reduces disease severity. A larger-scaled clinical trial is warranted to completely investigate the effects of PBM + H2 therapy on PD.